For the first time, the tumor suppressor miR-143-3p was shown to diminish the expression of cystatin, an oncogene that is significantly overexpressed in ovarian, bladder, hepatocellular, and colorectal cancer. This evidence concerns the gene CST4 and colorectal cancer.